Steering Committee
- Robert Capon, Senior Vice President, Adenosine Therapeutics Group, PGxHealth
- Doug Doerfler, President and CEO, MaxCyte, Inc.
- Joe Hernandez, Chairman, Principio
- Ron Laufer, M.D., Senior Managing Director, MedImmune Ventures
- Brandon Price, Ph.D., Principal Consultant, Falcon Ridge Associates
- Bruce Robertson, Managing Director, H.I.G. Ventures
- Ryan Schwarz, Managing Director, The Carlyle Group
- Dietrich Stephan, Ph.D., CEO, Ignite Institute
- Brad L. Stewart, President, Cylex
